Bausch Health Companies Inc (BHC)
8.56
+0.03
(+0.35%)
USD |
NYSE |
Apr 24, 16:00
8.565
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Price: 8.56 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 24, 2024 | 8.54 | 8.59 | 8.45 | 8.56 | 1.966M |
| Apr 23, 2024 | 8.50 | 8.62 | 8.43 | 8.53 | 4.025M |
| Apr 22, 2024 | 8.76 | 8.80 | 8.42 | 8.45 | 2.358M |
| Apr 19, 2024 | 8.57 | 8.76 | 8.545 | 8.69 | 2.946M |
| Apr 18, 2024 | 8.66 | 8.78 | 8.425 | 8.60 | 2.184M |
| Apr 17, 2024 | 8.80 | 8.926 | 8.651 | 8.66 | 2.199M |
| Apr 16, 2024 | 8.60 | 8.75 | 8.48 | 8.74 | 2.496M |
| Apr 15, 2024 | 8.80 | 8.98 | 8.565 | 8.63 | 3.191M |
| Apr 12, 2024 | 8.84 | 8.945 | 8.52 | 8.76 | 5.244M |
| Apr 11, 2024 | 8.91 | 9.870 | 8.36 | 8.97 | 15.23M |
| Apr 10, 2024 | 9.11 | 9.20 | 8.86 | 8.92 | 2.596M |
| Apr 09, 2024 | 9.71 | 9.73 | 9.055 | 9.26 | 3.895M |
| Apr 08, 2024 | 10.45 | 10.46 | 9.36 | 9.69 | 6.317M |
| Apr 05, 2024 | 10.07 | 10.48 | 10.06 | 10.41 | 4.491M |
| Apr 04, 2024 | 10.15 | 10.44 | 10.04 | 10.05 | 3.731M |
| Apr 03, 2024 | 10.10 | 11.46 | 9.945 | 10.04 | 6.739M |
| Apr 02, 2024 | 10.25 | 10.25 | 10.06 | 10.20 | 1.463M |
| Apr 01, 2024 | 10.59 | 10.72 | 10.33 | 10.40 | 2.748M |
| Mar 28, 2024 | 10.46 | 10.80 | 10.45 | 10.61 | 3.815M |
| Mar 27, 2024 | 9.90 | 10.49 | 9.88 | 10.49 | 6.336M |
| Mar 26, 2024 | 9.49 | 9.93 | 9.47 | 9.86 | 3.089M |
| Mar 25, 2024 | 9.64 | 9.89 | 9.47 | 9.48 | 2.192M |
| Mar 22, 2024 | 9.43 | 9.575 | 9.385 | 9.56 | 1.139M |
| Mar 21, 2024 | 9.54 | 9.625 | 9.43 | 9.50 | 1.684M |
| Mar 20, 2024 | 9.51 | 9.62 | 9.345 | 9.59 | 1.430M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.58
Minimum
Aug 02 2022
34.38
Maximum
Mar 11 2021
17.68
Average
18.31
Median
May 20 2020
Price Benchmarks
| Acasti Pharma Inc | 2.90 |
| Aurinia Pharmaceuticals Inc | 5.03 |
| Edesa Biotech Inc | 4.31 |
| Lexaria Bioscience Corp | 2.20 |
| Xenon Pharmaceuticals Inc | 39.50 |
Price Related Metrics
| PS Ratio | 0.3573 |
| PEG Ratio | -0.0328 |
| Price to Free Cash Flow | 4.116 |
| Earnings Yield | -18.93% |
| Market Cap | 3.139B |
| PEGY Ratio | -0.0328 |
| Operating PE Ratio | 1.955 |